2008 Presentations

UBC scientists participate in scientific and clinical meetings around the world. To learn more about a presentation, please contact the UBC scientist directly or call 301-654-9729.

  • Joint Congress of the European and International Societies for Sexual Medicine

    Dec 7 - Dec 10 2008
    Brussels, Belgium
    www.essm-issm-congress.org/
    Poster Presentation
    Content Validity of the Female Sexual Distress Scale-Revised (FSDS-R) in Women with Hypoactive Sexual Desire Disorder (HSDD)
    McCormack J, Hunter A, Harding G

  • 50th American Society of Hematology (ASH) Annual Meeting and Exposition

    Dec 6 - Dec 9 2008
    San Francisco, CA, USA
    www.hematology.org/
    Poster Presentation
    Impact of Management of Iron Overload in Patients with Myelodysplastic Syndrome
    Bozkaya D, Migliaccio-Walle K, Baladi JF

    Development of the Anemia Impact Measure (AIM): A Disease-Specific Patient Reported Outcome (PRO) Instrument to Measure Anemia Symptoms and Their Impact on Functioning in Cancer Patients Receiving Chemotherapy
    Kleinman L, Benjamin K, Viswanathan H, Stoeckl Mattera M, Bosserman LD, Blayney DW, Revicki D

  • CBI's 3rd Forum on Patient Reported Outcomes (PRO)

    Nov 19 - Nov 20 2008
    King of Prussia, PA, USA
    www.cbinet.com/pro

    Session
    Analyze FDA Requirements for PRO Studies and Discuss Next Steps if FDA Rejects a PRO Claim
    William R. Lenderking, PhD, Senior Research Scientist, United BioSource Corporation and
    Jeff Sloan, PhD, Lead Statistician, Mayo Clinic

    Analyze Industry Experience with the FDA and Discuss Anticipated Changes from the Revised Guidance
    William R. Lenderking, PhD, Senior Research Scientist, United BioSource Corporation and
    Jeff Sloan, PhD, Lead Statistician, Mayo Clinic

  • 2008 NPC (National Pharmaceutical Council) Annual Forum

    Nov 13 - Nov 14 2008
    Arlington, VA, USA
    www.npcnow.org
    Session
    What Evidence Do Payers Need?
    Moderator: Bryan R. Luce, PhD, MBA, SVP, Science Policy, United BioSource Corporation

  • ISPOR 11th Annual European Congress

    Nov 8 - Nov 11 2008
    Athens, Greece
    www.ispor.org


    Educational Symposium Sponsored by UBC

    Nov. 10: 7 a.m. - 8 a.m.

    Risk-Sharing Agreements: All Pain or Some Gain?
    Moderator: J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Health Economics, United BioSource Corporation, Lexington, MA, USA
    Speakers: Sean Sullivan, PhD, Professor and Director, Pharmaceutical OR and Policy Program, University of Washington, Seattle, WA, USA; Jens Grueger, PhD, Global Head, Pricing and Reimbursement, Novartis Pharma AG, Basel, Switzerland; and, Andrew Eggleston, BPharm, MMedSc, Associate Director, Health Economics, Janssen-Cilag, North Ryde, Australia


    Educational Symposium

    Nov. 11: 7:00 a.m. - 8 a.m.

    The Do's and Don'ts with Agencies like NICE or IQWiG -- Generating the Right Health Economic Data for Successful Appraisals
    Gathering the Right Data for Successful IQWiG Appraisals
    J. Jaime Caro, MDCM, FRCPC, FACP, Chair of Expert Committee Advising Institute for Quality and Efficiency in Health Care (IQWiG), Lexington, MA, USA


    Short Courses

    Nov. 8: All Day Course

    Discrete Event Simulation for Economic Analyses
    Faculty: J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatics, McGill University, Montréal PQ and Senior Vice President of Health Economics, United BioSource Corporation, Lexington, MA, USA; Jörgen Möller, MSc Mech Eng, Vice President, Modeling, United BioSource Corporation, Eslov, Sweden


    Forum

    Nov. 11: 8:30 a.m. - 9:30 a.m.

    Patient Reported Outcomes Good Research Practices
    Presented by: The ISPOR Patient-Reported Outcomes SIG
    Moderator: Donald Patrick, PhD, MSPH, ISPOR PRO Task Force Developer and Member; Professor, University of Washington, Seattle, WA, USA
    Speakers: Nancy Kline Leidy, PhD, ISPOR PRO Existing Instruments and Their Modifications Task Force Member, Senior Vice President of Scientific Affairs, United BioSource Corporation, Bethesda, MD, USA; Keith Wenzel, BS, ISPOR ePRO Task Force Member and Product Director, ePRO, Perceptive Informatics Inc., Boston, MA, USA; Diane Wild, MSc, Chair, ISPOR PRO Translation and Linguistic Validation Task Force and Director, Oxford Outcomes, Oxford, UK



    Issue Panels

    Nov. 10: Issue Panel – Session I

    Discrete Event Simulation or Markov Model: War of the Worlds or Expanding the Galaxy?
    Moderator: Bengt Jönsson, PhD, Professor of Health Economics, Stockholm School of Economics, Stockholm, Sweden
    Panelists: J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President Health Economics, United BioSource Corporation, Lexington, MA, USA; Mark J. Sculpher, PhD, Professor, University of York, York, UK; Andrea Manca, PhD, Research Fellow, University of York, York, UK

    Nov. 11: Issue Panel – Session II

    Public-Private Partnerships in PRO Instrument Development: An Idea Whose Time Has Come?
    Moderator: Nancy Kline Leidy, PhD, Senior Vice President Scientific Affairs, United BioSource Corporation, Bethesda, MD, USA
    Panelists: Laurie B. Burke, RPh, MPH, Director, FDA/CDER/OND-IO, Silver Spring, MD, USA; Asha Hareendran, PhD, Senior Director, Global Outcomes Research, Pfizer, Ltd, UK & Chair, COPD PRO Working Group of the EFPIA Innovation Medicines Initiative (IMI) Respiratory calls, Sandwich, UK; Ingela Wiklund, PhD, Director, Global Health Outcomes, GlaxoSmithKline, UK & Co-Chair, COPD PRO Working Group of the EFPIA Innovative Medicines Initiative (IMI) Respiratory calls, Uxbridge, Middlesex, UK


    Workshop Sessions

    Nov. 10: Workshop Session II

    Trivial or Important: The Needs, Benefits and Implications of Variability
    Discussion Leaders: Denis Getsios, BA, Research Scientist, United BioSource Corporation, Lexington, MA, USA; Kristen Migliaccio-Walle, BS, Director and Research Scientist, Health Economics, United BioSource Corporation, Lexington, MA, USA; Duygu Bozkaya, MSc, MBA, Researcher, United BioSource Corporation, Lexington, MA, USA

    Nov. 11: Workshop Session III

    Quantifying and Displaying Uncertainty Around an Efficiency Frontier
    Discussion Leaders: Isao Kamae, MD, DrPH, Professor, Keio University Graduate School of Health Management, Fujisawa, Kanagawa, Japan; J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President Health Economics, United BioSource Corporation, Lexington, MA, USA

    Nov. 11: Workshop Session IV

    Collaborative Multi-National Health Economic and PRO Data Gathering: A Case Study Highlighting the Athens Stroke Registry
    Discussion Leaders: Krista Payne, MEd, Director & Research Scientist, United BioSource Corporation, Montreal, QC, Canada; Kostas Vemnos, MD, Professor, University of Athens School of Medicine, Alexandra Hospital, Athens, Greece; Liberty Fajutrao, MD, MSc, Senior Health Economics and Outcome Research Scientist, AstraZeneca R&D, Sodertalje, Sweden


    Podium Presentations

    Nov. 9: Podium Session II

    Interpreting Scores on Three COPD Patient-Reported Outcome Measures
    McKenna SP, Twiss J, Meads DM, Revicki D, Pokrzywinski R, Gale R

    Predicted Optimal Lipid Value Attainment with the Co-Administration of Fenofibric Acid and a Statin Compared to Statin Monotherapy in Patients with Multiple Lipid Abnormalities
    Sorensen SV, Webb SF, Burge RT

    Nov. 10: Podium Session III

    Cost of Initial Prostate Cancer Treatment Following Diagnosis per Patient by Stage: Estimates from the UK, France, Germany, Italy and Spain
    Benedict Á, Black L, Stokes ME


    Poster Presentations

    Nov. 9: Poster Session I

    Cost-Effectiveness of Niaspan versus Zetia as Add-On Treatment To Statin Therapy In High-Risk Patients
    Sorensen SV, Webb SF, Burge RT

    Cost-Effectiveness of Targeting Multiple Lipid Parameters (LDL-C, HDL-C, TG) With Niaspan versus a Single Lipid Parameter (LDL-C) With Zetia In Patients Receiving On-Going Statin Therapy
    Sorensen SV, Webb SF, Burge RT

    Costs of Bleeds Associated with Treating Acute Coronary Syndrome Patients in Germany
    Bufe A, Briswalter S, Brown R

    The EXACT-PRO Initiative: Development and Validation of a Single Patient-Reported Outcome Measure for Evaluating Exacerbations of Chronic Obstructive Pulmonary Disease
    Leidy NK, Wilcox T, Roberts L, Winnette R, Murray L and the EXACT-PRO Study Group

    Modeled Cost-Effectiveness of Achieving Multiple Lipid Targets When Fenofibric Acid Is Co-Administered With Simvastatin, Rosuvastatin, and Atorvastatin
    Webb SF, Burge RT, Sorensen SV

    Patient Outcomes and Health Economics Associated with the Use of Octylcyanoacrolate Topical Skin Adhesive in CABG Surgery
    Fraeman KH, Reynolds MW, Vaughn B, De Lissovoy G

    Persistence with Amiodarone or Sotalol and its Impact on Atrial Fibrillation-Related Hospitalizations and Cardioversion
    Ishak KJ, Proskorovsky I, Guo S, Lin J, Caro JJ

    Predicted Cardiovascular Event Reduction with the Co-Administration of Fenofibric Acid and Statins in a Dyslipidemia Patient Cohort
    Sorensen SV, Webb SF, Burge RT

    Stroke Patient Resource Use and Caregiver Burden Outcomes by Severity (Recovery) Study: Methods and Results from the Athens Stroke Registry
    Payne K, Caro JJ, Lordan N, Huybrechts KF, Ishak KJ, Rylander A, Vemnos K

    Nov. 10: Poster Session II

    Comparing Time and Supplies Usage Associated with a New Skin Closure Device vs. Standard of Care Wound Closure for Abdominoplasty Surgery in the Netherlands
    Van Nooten F, De Cock E, Fabré J, Tan R

    Changing the Surgical Wound Closure Management Pathway: Time and Supplies with PRINEO vs. Standard of Care for Abdominoplasty Surgery in Germany
    De Cock E, van Nooten F, Mueller K, Tan R

    Economic Evaluation of Sunitinib First-Line for Metastatic Renal Cell Carcinoma versus Sorafenib, Temsirolimus and Bevacizumab + Interferon-Alfa in the Swedish Health Service Setting
    Munir U, Benedict Á, Borgman B, Sandin R, Harmenberg U, Ullén A, Sandström P

    Nov. 11: Poster Session III

    Content Validity of the Subject’s Assessment of Condition, Subject’s Assessment of Treatment Satisfaction, King’s Health Questionnaire (KHQ), and the International Consultation on Incontinence Questionnaire – Short Form in Patients with OAB
    Margolis MK, Coyne KS, Vats V

    Economic Implications of Iron Chelation in Patients with Refractory Anemia Related to Myelodysplastic Syndrome
    Migliaccio-Walle K, Baladi JF

    Methods for Addressing Use of PRO Instruments in the Same Language for Different Countries: Best Practice Guidelines for Decision-Making and Translation or Adaptation
    Eremenco S, Houchin C, Gawlicki M, Chong LY

    Psychometric Evaluation of the KHQ in Ten Languages
    Coyne K, Margolis MK, Weinstein D, Ebel-Bitoun C

    Validation of the Urinary Sensation Scale (USS)
    Coyne KS, Margolis MK, Jumadilova Z, Vats V, Hsieh R


    Plenary Sessions

    Nov. 11: Third Plenary Session

    Can We Agree on International Guidelines for Economic Evaluation of Health Care Interventions?
    Is Efficiency Frontier Approach the Answer?
    Speaker: J. Jaime Caro, MD, Senior Vice President of Health Economics, United BioSource Corporation, Lexington, MA, USA

  • 2008 Annual Meeting of the American College of Allergy, Asthma & Immunology

    Nov 6 - Nov 11 2008
    Seattle, WA, USA
    www.acaai.org/Member/Annual_Meeting/Annual+Meeting.htm
    Presentations
    Can Patients With Asthma Feel Inhaler Therapy Working Right Away? A Clinical Trial Testing the Influence of Daily Versus Weekly Assessment on Patient Perception
    Leidy NK, Gutierrez B, Lampl K, Uryniak T, O'Brien C

    Can Patients With Asthma Feel Inhaler Therapy Working Right Away? A Clinical Trial Testing the Influence of Predose Versus Postdose Assessment on Patient Perception
    Leidy NK, Gutierrez B, Lampl K, Uryniak T, O'Brien C

    Patient Perception of Onset of Effect: Results of Exit Interviews From Two Clinical Trials in Patients With Asthma
    Petrillo J, Walter K, Harding G, Leidy NK, Gutierrez B, O'Brien C

    Relationship of Nasal Congestion and Ocular Symptoms with Patient-Reported Sleep, Mood, and Productivity
    Stull DE, Schaefer M, Sandor D, Crespi S

  • AHIP's Medical Leadership Forum: Health Care's Challenges in a Changing Political Environment

    Nov 5 - Nov 7 2008
    Naples, FL, USA
    www.ahip.org/links/medicalleader2008/

    Poster Abstract
    The Emperor's Clothes: Comparative Effectiveness in Perspective
    Singer Cohen R, Luce BR

  • 34th Annual Scientific Meeting of the Australian Atherosclerosis Society

    Oct 28 - Oct 31 2008
    Bondi Beach, New South Wales
    www.meetingsfirst.com.au/meetings/aas08/site/index.html

    Poster Presentation
    Psychometric Qualities of the Flushing ASsessment Tool (FAST)
    Thakkar R, Revicki DA, Davidson MH, Punzi HA, Kawata AK, Jiang P, Krause S, Padley R

  • ACR / ARHP 2008 Annual Scientific Meeting

    Oct 24 - Oct 29 2008
    San Francisco, CA, USA
    www.rheumatology.org/annual/index.asp
    Poster
    Improvement in Health-Related Quality of Life (HRQL) and Disability Index in Treatment Failure Gout (TFG) after Pegloticase (PGL) Therapy: Pooled Results from GOUT1 and GOUT2, Phase 3, Randomized, Double Blind, Placebo (PBO)-Controlled Trials
    Edwards NL, Baraf HS, Becker MA, Gutierrez-Urena SR, Sundy JS, Treadwell EL, Vazquez-Mellado, Yood RA, Kawata AK, Benjamin KL, Horowitz Z, Huang B, Maroli A, Waltrip R

  • 15th Annual Conference of the International Society for Quality of Life Research (ISOQOL)

    Oct 22 - Oct 25 2008
    Montevideo, Uruguay
    www.isoqol.org/

    Workshop Presentations
    Advanced Psychometric Methods, Part 1: Use of Exploratory and Confirmatory Factor Analyses in PRO Instrument Development and Evaluation
    Instructors: Donald E. Stull and Margaret K. Vernon, United BioSource Corporation, USA

    Coping With the Validation Requirements of the FDA PRO Guidance: The Intersection of Science and Practice
    Instructors: William R. Lenderking, United BioSource Corporation, Lexington, MA, USA; Elizabeth Merikle, United BioSource Corporation, Montreal, Canada; and, Michelle Steward, Pfizer, New London, CT, USA

    Advanced Psychometric Methods, Part 2: Executing and Interpreting Exploratory and Confirmatory Factor Analyses in PRO Instrument Development and Evaluation
    Instructors: Donald E. Stull and Margaret K. Vernon, United BioSource Corporation, USA

    Evaluating Changes in Health-Related Quality of Life Measures and Other Patient-Reported Outcomes
    Instructor: Kathleen W. Wyrwich, United BioSource Corporation, USA

    Symposiums
    Measurement Tools to Enhance Health-Related Quality of Life Research: The Patient-Reported Outcomes Measurement Information System (PROMIS)
    Reeve BB, Cella D, Revicki DA, Hays RD
    Challenges and Advantages for PROMIS Instruments for Clinical Research
    Speaker: Dennis A. Revicki, PhD, United BioSource Corporation, Bethesda, MD, USA

    Special Symposium on Patient-Reported Outcomes (PROs) and Reimbursement Decision Making
    Incorporating the Views of Patients and Society in Reimbursement Decisions
    Moderator: William R. Lenderking, PhD, United BioSource Corporation, Lexington, MA, USA
    Speakers: John Brazier, PhD, University of Sheffield, Sheffield, UK; David Bruhn, Eli Lilly and Co., Indianapolis, IN, USA; Wilson Follador, Sanofi-Aventis, Brazil; Paul Kind, PhD, University of York, York, UK; Federico Augustovski, Universidad de Buenos Aires, Argentina

    Plenary Session
    Plenary V: QoL in Mental Health: Burden of Disease
    Chair: Marcello Fleck
    Speakers: Jordi Alonso, Dennis Revicki, George Awad
    Burden of Generalized Anxiety Disorder on Health-Related Quality of Life: European and U.S. Studies
    Revicki DA

    Sessions
    Cross Cultural Adaptation of Instruments
    Chair: Sonya Eremenco, United BioSource Corporation, Bethesda, MD, USA

    Mental Health
    Chair: Louis Matza, United BioSource Corporation, Bethesda, MD, USA

    Podium Presentation
    Some Determinants of HRQL in Patients with ESRD: The Case of Uruguay
    Stull DE, Depueto J, Galain AI

    Poster Presentations
    Anemia Symptoms and Symptom Impacts in Patients Receiving Chemotherapy: A Conceptual Framework for Development of a Patient-Reported Outcome (PRO) Measure
    Revicki DA, Benjamin K, Kleinman L, Bosserman LD, Blayney DW, Viswanathan HN

    Modeling the Effects of Darbepoetin Alfa (DA) in Randomized Placebo Controlled Trials Using Latent Growth Curve Models
    Stull D, Vernon M, Viswanathan HN, Tomita D, Rader ME, Fairclough D, Revicki DA

    Use of Latent Growth Curve Models for Assessing the Effects of Darbepoetin Alfa on Hemoglobin and Fatigue
    Stull D, Vernon M, Viswanathan HN, Legg J, Rader ME, Fairclough D, Revicki DA

    Comparing Differential Item Functioning in Quality of Life Measures Between Children With and Without Special Health Care Needs
    Huang I-C, Knapp C, Revicki DA, Thompson L, Nogle J, Shenkman E

    Establishing Clinically Meaningful Cutoff Scores for a Pediatric Health-Related Quality of Life (HRQOL) Measures
    Shenkman E, Huang I-C, Thompson L, Knapp C, Revicki DA

    Test-Retest Reliability of Two Patient-Reported Outcomes Measures for Use in Adults with ADHD
    Matza LS, Van Brunt DL, Cates C, Murray L

    Validation of the ASK-12 Survey Assessing Barriers to Medication Adherence
    Matza LS, Coyne KS, Park J, Skinner EP, Wakefield J, Malley K, Flowers P, Quillian Wolever R

  • 30th Annual Meeting of the Society for Medical Decision Making - Comparative Effectiveness Research: Practice and Policy; Challenges and Opportunities

    Oct 18 - Oct 22 2008
    Philadelphia, PA, USA
    www.smdm.org/
    Short Course
    Issues in Comparative Effectiveness Research: Seeking Efficiency Exploring Bayesian Adaptive Trial Methods
    Faculty: Bryan R. Luce, PhD, MBA, Leonard Davis Institute University of Pennsylvania and United BioSource Corporation; Anirban Basu, PhD, University of Chicago; Jason Connor, PhD, Berry Consultants; Michael Krams, MD, Wyeth Pharmaceuticals; Donal Buesching, PhD, Eli Lilly; Jaime Caro, United BioSource Corporation

  • International Society for CNS Clinical Trials and Methodology (ISCTM) 2008 Autumn Conference

    Oct 6 - Oct 7 2008
    Toronto, Ontario, Canada
    www.isctm.org

    Presentation
    U.S. Perspective on Alzheimer's Disease Outcomes Measurement
    Frank L

    Posters
    Cultural Variability in the ADAS-Cog Utilization
    Miller D., Bartko J.,  Connor D.

    Ratings Surveillance to Identify Rater Errors
    Miller D., Hurt S., Dewerth-Pallmeyer A., Samuelson P., van der Putten D., Jones L., Butler A.

     

  • European Respiratory Society 18th Annual Congress (ERS)

    Oct 4 - Oct 8 2008
    Berlin, Germany
    www.ersnet.org
    Poster Presentations
    Factors That Predict Exacerbation Severity and Recovery Measured With the Exacerbations of Chronic Obstructive Pulmonary Disease (EXACT) Tool
    Wilcox T, Sethi S, Leidy NK

    Managing Sub-Optimal Treatment in COPD: Development of an Assessment Tool for Primary Care
    Jones P, Harding G, Wiklund I, Berry P, Leidy NK

    Development and Pilot Testing of a New 7-Item Cough Severity Patient-Reported Outcome Measure
    Vernon MK, Leidy NK, Nacson A, Nelsen LM

    Satellite Symposium
    Improving Outcomes in COPD: Developing a Patient Assessment Test
    Leidy NK, Guest Faculty, Panel Discussion

  • DIA: Evidence-Based Medicine and Health Technology Assessment: Can We Find Common Ground?

    Sep 22 - Sep 23 2008
    Alexandria, VA, USA
    www.diahome.org

    Oral Presentation
    The Three HTA-Related Evidence Tracks
    Luce BR

  • IUGA 33rd Annual Meeting

    Sep 15 - Sep 17 2008
    Taipei, Taiwan
    www.IUGA2008.org
    Presentation
    Health-Related Quality of Life Differences Between Men and Women with OAB Treated with Fesoterodine
    Coyne KS, Margolis MK, Weinstein D, Ebel-Bitoun C, Khullar V

  • NESUG 2008 (NorthEast SAS Users Group)

    Sep 14 - Sep 17 2008
    Pittsburgh, PA, USA
    www.nesug.org
    Abstracts
    Common Sense Tips and Clever Tricks for Programming with Extremely Large SAS Data Sets
    Fraeman K

    Just What the Doctor Ordered: Using SAS to Calculate Patient Drug Dose with Electronic Medical Record (EMR) Prescription Data
    Fraeman K

    Get Into the Groove with %SYSFUNC: Generalizing SAS Macros with Conditionally Executed Code
    Fraeman K

  • 33rd ESMO (European Society for Medical Oncology) Congress

    Sep 12 - Sep 16 2008
    Stockholm, Sweden
    www.esmo.org/
    Cost-Effectiveness of Sunitinib (SU) vs Sorafenib (SFN), Temsirolimus (TMS) and Bevacizumab + Interferon-Alfa (BEV / IFN) as First-Line Therapy for Metastatic Renal Cell Carcinoma (mRCC) - Adaptation for the Swedish Health Service
    Munir U, Benedict Á, Borgman B, Sandin R, Ullén A, Harmenberg U, Sandström P

  • AUGS 29th Annual Scientific Meeting

    Sep 4 - Sep 6 2008
    Chicago, IL, USA
    www.augs.org

    Presentation
    Psychometric Validation of the King's Health Questionnaire in Paitents with Overactive Bladder in the United States
    Coyne KS, Margolis MK, Vats V, Kelleher C

  • Canadian Psychiatric Association's 58th Annual Conference

    Sep 4 - Sep 7 2008
    Vancouver, BC, Canada
    www.cpa-apc.org/
    Symposium
    Improving Clinical and Health Economic Outcomes: Promoting Cost-Effective Delivery of Evidence-Based Mental Health Care in Canada
    Myhr G, Payne KA, Vasiladis H-M, Racine H

    Abstracts
    Increasing Access to Cognitive-Behavioural Therapy in Canada: A Research Framework and Call for Action
    Payne KA, Myhr G

    Practical Challenges in Increasing Access to Cognitive-Behavioural Therapy in Canada
    Myhr G, Payne KA

  • Third ICOH International Conference on Psychosocial Factors at Work

    Sep 1 - Sep 4 2008
    Quebec City, Quebec, Canada
    www.icoh-wops2008.com/

    Symposium: Measuring Return to Work I: From Being "Off Work" to "Work Re-entry"
    Measuring Return to Work
    Radoslaw Wasiak, Amanda Young, Richard Roessler, Kathryn McPherson, Mireille van Poppel, Johannes (Han) Anema

    Symposium: Measuring Return to Work II: How to Assess Return-to-Work Maintenance and Advacement?
    How to Analyze Recurrent Disability Outcomes
    Sheila Hogg-Johnson, Radoslaw Wasiak, Jill Hayden, Renée-Louise Franche

  • 24th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE 2008)

    Aug 17 - Aug 20 2008
    Copenhagen, Denmark
    www.pharmacoepi.org
    Poster Presentation
    Management and Cost of Parkinson's Disease in the United States
    O'Brien JA, Ward A, Duran PA, Pitoniak-Morse C, Michels S, Tzivelekis S

  • Alzheimer's Association International Conference on Alzheimer's Disease 2008 (ICAD)

    Jul 26 - Jul 31 2008
    Chicago, IL, USA
    www.alz.org/icad
    Poster Presentations
    Administration and Scoring Variability Among ADAS-Cog Raters
    Miller D, Connor D, Bartko J

    Subjective Item Variability In the ADAS-Cog
    Miller D, Samuelson P, Butler A

    Measuring Patient Dependence on Caregivers in Alzheimer's Disease: Dependence Scale Content Assessment
    Frank L, Howard K, McLaughlin T, Mannix S, Leibman C

  • 7th European Conference on Health Economics

    Jul 23 - Jul 26 2008
    Rome, Italy
    www.echeroma2008.eu
    Poster Presentations
    Health Economic Evaluations in Germany: The New IQWiG Methods
    Caro J

    Does Social Capital Affect Smoking Habits?

  • 2008 Joint Scientific Meeting of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism

    Jun 27 - Jul 2 2008
    Washington, DC, USA
    www.rsoa.org/2008meet-indexRegistration.htm

    Poster Presentation
    Participant and Expert Views of Craving and Consequence Measures
    Werner M, Rentz A, Frank L, Bowman L, Duhig A, Moss H

  • 2nd Biennial Conference of the American Society of Health Economists (ASHE)

    Jun 22 - Jun 25 2008
    Durham, NC, USA
    www.healtheconomics.us/
    Poster Presentation
    Medical Cost of Osteoporosis in the Elderly Medicare Population
    Blume SW, Kahler KH, Paramore C, Chan W, Curtis JR, Saag K

  • 12th International Congress of Parkinson's Disease and Movement Disorders

    Jun 22 - Jun 26 2008
    Chicago, IL, USA
    www.movementdisorders.org

    Abstract
    Annual Cost of Parkinson's Disease in the United States
    O'Brien JA, Duran PA, Pitoniak-Morse C, Michels S, Tzivelekis S, Ward A

  • 13th Congress of the European Hematology Association Conference

    Jun 12 - Jun 15 2008
    Copenhagen, Denmark
    www.ehaweb.org/congress

    Poster Presentation
    Economic Evaluation of Lenalidomide for the Treatment of Multiple Myeloma in Wales in Patients Who Have Received at Least One Prior Therapy
    Deniz B, Ishak J, Edwards D, Shearer A, Dale P, Caro J

  • EULAR Congress 2008

    Jun 11 - Jun 14 2008
    Paris, France
    www.eular.org

    Poster Presentation
    Treatment of Rheumatoid Arthritis After Failure of TNF Antagonists: A Systematic Review and Meta-Analysis
    Nalysnyk L, Xu Y, Williams K, Sharma S, Villanueva I, Sallerin V, Koncz T

  • 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS)

    Jun 7 - Jun 12 2008
    Baltimore, MD, USA
    www.sleepmeeting.org/
    Poster Presentations
    Development of an Excessive Daytime Sleepiness Diary
    Vernon MK, O'Quinn S, McQuarrie K, Norquist JM, Dinges D, Roth T, Herring
    WJ, Brodovicz KG
     
    Experiences with Excessive Sleepiness from Patients’ Perspectives
    Vernon MK, O'Quinn S, McQuarrie K, Norquist JM, Herring WJ, Brodovicz KG

  • XXVII Congress of the European Academy of Allergology and Clinical Immunology 2008 (EAACI)

    Jun 7 - Jun 11 2008
    Barcelona, Spain
    www.eaaci2008.com
    Poster Presentations
    Nasal Congestion as a Primary Symptom of Allergic Rhinitis: Results from a Patient Preference Survey
     
    Use of and Satisfaction with Prescription Medications for Treatment of Chronic Urticaria

  • XXXIX Nordic Meeting of Gastroenterology

    Jun 4 - Jun 6 2008
    Helsinki, Finland

    Presentation
    Patient Perspectives on Gastrointestinal Symptoms During Use of Low-Dose Acetylsalicylic Acid for Cardiovascular Risk Management
    Margolis MK, Halling K, Sörstadius E, Manson S, Coyne KS

  • Society for Medical Decision Making SMDM Europe 2008

    Jun 1 - Jun 4 2008
    Engelberg, Switzerland
    www.smdmeurope2008.com

    Poster Presentation
    Secondary Prevention of Stroke for Patients on Antiplatelet Treatment in the UK
    Benedict A

  • 44th ASCO Annual Meeting 2008

    May 30 - Jun 3 2008
    Chicago, IL, USA
    www.asco.org/ASCO/Meetings/ASCO+Annual+Meeting
    Poster Presentations
    Economic Evaluation of Sorafenib vs. Best Supportive Care in Hepatocellular Carcinoma
    Muszbek N, Shah S, Carroll SM, Carr BI, Gondek K
     
    The Effect of Darbepoetin Alfa on Patient-Reported Fatigue in Cancer Patients: Results from Three Phase III Clinical Trials
    Revicki D, Stull D, Viswanathan H, Tomita D, Rader ME, Fairclough D
     
    Economic Evaluation of Sunitinib, Sorafenib, Bevacizumab and Temsirolimus in First-Line Metastatic Renal Cell Carcinoma (mRCC) – An Indirect Comparison
    Benedict A, Charbonneau C, Hidi J, Kim ST, Négrier S
    Transfusion outcomes in erythropoiesis-stimulating agent (ESA)-treated cancer chemotherapy patients based on achieved hemoglobin (hb) levels.
    Larholt K, Burton T, Boulanger L, et al.

  • 48th Annual NCDEU Meeting (New Clinical Drug Evaluation Unit)

    May 27 - May 30 2008
    Phoenix, AZ, USA
    www.nimh.nih.gov/research-funding/scientific-meetings/recurring-meetings/ncdeu/index.shtml
    Poster Presentations
    Development and Initial Psychometric Exploration of a Clinical Global Impression Scale for Schizoaffective Disorder (CGI-SCA)
    Allen MH, Bartko J, Lindenmayer JP, Daniel D, Canuso C, Kosik-Gonzalez C, Adams J, Revicki D, Garibaldi G

    Rater Drift In CNS Clinical Trials
    Daniel D, Bartko J, Allen M

    CGI Scoring Ambiguity Can Adversely Affect Clinical Trials
    Targum S, Busner J, Dunn J

    CGI Ratings in Generalized Anxiety Disorder: A Training Intervention to Address the Confunding Effects of Physical and Psychiatric Adverse Events
    Busner J, Targum S, Dunn J

    Workshop
    Global Assessments in CNS Clinical Trials-Evolution and Future Trials
    To Be Co-Chaired by David G. Daniel, MD and Robert M. Post, MD 
    Lindenmayer J, Canuso C, Allen M

  • Digestive Disease Week 2008 (DDW)

    May 17 - May 22 2008
    San Diego, CA, USA
    www.ddw.org
    Poster Presentation
    Reliability, Validity and Responsiveness of the Patient Assessment of Upper Gastrointestinal Disorders - Quality of Life (PAGI-QOL) and Symptom Severity Index (PAGI-SYM) in Patients with Erosive Esophagitis (EE)
    Harnam N, Lee M, Mody R, Larsen L, Revicki DA, Wyrwich KW

  • American Urological Association 2008 Annual Meeting (AUA)

    May 17 - May 22 2008
    Orlando, FL, USA
    www.aua2008.org
    Podium Presentations
    The Impact of Lower Urinary Tract Symptoms on Men’s Sexual Health: Results from EpiLUTS
    Coyne KS, Sexton C, Kopp Z, Irwin D, Milsom, Aiye L, Wein A, Chapple C, Tubaro A
     
    The Impact of Lower Urinary Tract Symptoms on Women’s Sexual Health: Results From the EpiLUTS Study
    Coyne KS, Sexton C, Kopp Z, Thompson C, Irwin D, Milsom, Chapple C, Tubaro A, Wein A

    Total Cost in the 1st Year Following Diagnosis of Prostate Cancer: Estimates from US SEER-Medicare Data
    Roehrborn CG, Stokes ME, Benedict A, Albertsen PC, Black LK

  • American Thoracic Society 2008 International Conference (ATS)

    May 16 - May 21 2008
    Toronto, Ontario, Canada
    www.thoracic.org/
    Poster Presentations
    Attributes of Cough Severity from the Patients' Perspective

    Measurement of Cough Severity: A Review of the Literature
    Vernon MK, Leidy NK, Nacson A, Nelsen LM

    Day-to-Day Severity and Variability of Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): What are Patients Telling Us?
    Leidy NK, Mannix S, Vernon MK, Goldman M, Ramachandran S

  • APA 161st Annual Meeting 2008 (American Psychiatric Association)

    May 3 - May 8 2008
    Washington, DC, USA
    www.psych.org
    Poster Presentations
    A Review of the Humanistic and Economic Outcomes in European Patients Diagnosed with Generalized Anxiety Disorder
    Wyrwich KW, Stoeckl M, Svedsäter H, Locklear J, Revicki DA, Montgomery S
     
    Humanistic and Economic Burden in European Patients Diagnosed with Major Depressive Disorder
    McIntyre RS, de Jonge PH, Stafford M, Hearn S, Tschaut N, Svedsäter H, Locklear J, Revicki DA, Brown R

    Cost-Utility Analysis of Switching Antipsychotic to Quetiapine XR Due to Insufficient Efficacy or Tolerability in Patients with Schizophrenia
    Järbrink K, Kreif N, Benedict A, Locklear J

  • ISPOR Annual International Meeting 2008

    May 3 - May 7 2008
    Toronto, Ontario, Canada
    www.ispor.org
    Short Courses
     
    Saturday, May 3, 2008
     
    Bayesian Analysis: Overview & Applications
    Faculty: Bryan Luce MBA, PhD, Sr. Vice President, Science Policy, United BioSource Corp., Bethesda, MD, USA; Christopher S. Hollenbeak, PhD, Asst. Professor, Surgery and Health Evaluation Sciences, Penn State College of Medicine, Hershey, PA, USA; David Vanness PhD, Asst. Professor of Population Health Sciences, University of Wisconsin Medical School, Madison, WI, USA
     
    Finding and Extracting Cost Data
    Faculty: Gregory de Lissovoy MPH, PhD, Vice-President, United BioSource Corp., Bethesda, MD, USA; L. Clark Paramore MSPH, Executive Director and Research Scientist, Center for Health Economics, Epidemiology & Science Policy, United BioSource Corp., Medford, MA, USA

    Sunday, May 4, 2008
     
    Bayesian Analysis – Advanced
    Faculty: Bryan Luce MBA, PhD, Sr. Vice President, Science Policy, United BioSource Corp., Bethesda, MD, USA; Christopher S. Hollenbeak, PhD, Asst. Professor, Surgery and Health Evaluation Sciences, Penn State College of Medicine, Hershey, PA, USA; David Vanness PhD, Asst. Professor of Population Health Sciences, University of Wisconsin Medical School, Madison, WI, USA
     
    Discrete Event Simulation for Economic Analyses
    Faculty: J. Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of Epidemiology and Biostatistics, McGill University, Montreal PQ & Senior Vice-President of Health Economics, United BioSource Corp., Concord, MA, USA; Jörgen Möller, MSc, Mech Eng, Simulation Specialist, United BioSource Corp., Eslov, Sweden
     
    Open Forums
     
    Monday, May 5, 2008
     
    Patient Registry SIG Breakfast Forum: Registry Design, Operations, Data & Taxonomy
    Speakers: Patient Registry SIG Working Group Chairs: Chris L. Pashos PhD,Vice President and Executive Director, HERQuLES. Abt Associates; Leanne R. Larson MHA Vice President, Registry Consulting, Ovation Research Group / ICON Clinical Research; Annette Stemhagen, DrPH, FISPE, Vice President, Epidemiology and Risk Management, United BioSource Corp.
     
    PRO - Changing Culture or Language of a Instrument Task Force Forum: Multinational trials - What Translations are Required, What Methodology Should be used and What Methodology Supports Pooling the Data?
    Moderator: Diane Wild MSc, Director, Oxford Outcomes Ltd, Oxford, UK
    Speakers: Isabelle Mear MA, Managing Director, Mapi Research Institute, Linguistic Validation, Lyon, France; Sonya Eremenco MA, ePRO Manager, United BioSource Corp., Bethesda, MD, USA
     
    Issues Panel
     
    May 5- Issues Panel- Session I
     
    Comparative Effectiveness Research: Breaking the Methods Mold
    Moderator: Sean Tunis, MD MSc, Director, Center for Medical Technology Policy, San Francisco, CA, USA
    Panelist(s): Bryan R. Luce, PhD, MBA, Senior Vice President, United BioSource Corp., Bethesda, MD, USA; Scott Berry PhD (invited), President, Senior Statistical Scientist, Berry Consultants, College Station, TX, USA; Michael Krams MD (invited), Assistant Vice President of Adaptive Trials, Clinical Development, Wyeth Research, Collegeville, PA, USA

    Podium Presentations
     
    May 5- Podium Session I: Health Care Decision-Maker’s Case Studies I
     
    Economic Analysis of Implantable Cardioverter Defibrillators (ICDs) in Primary Prevention of Sudden Cardiac Death- A Canadian Perspective
    Deniz B, Sadri H
     
    May 5- Podium Session II: Cancer Outcomes Research
     
    Costs Associated with Neutropenia in Elderly Patients Treated First-Line for Advanced Non-Small Cell Lung Cancer (NSCLC)
    Stokes M, Muehlenbein C, Marciniak M, Faries D, Motabar S, Buesching D, Gillespie T, Lipscomb J, Knopf K
     
    Workshop Presentations
     
    May 5- Workshops Session III
     
    An Unbiased Overview and Understanding of the Use of Propensity Scoring In Pharmacoeconomic And Pharmacoepidemiology Research
    Discussion Leaders: Matthew W Reynolds, PhD, Director, United BioSource Corp., Medford, MA, USA.; Chris Hollenbeak, Ph.D.; David Vanness, Ph.D., University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
     
    Selecting, Evaluating and Documenting Support for Existing Instruments for Making Labeling Claims: Content Validity
    Discussion Leaders:  Pennifer Erickson, PhD, Founder, OLGA, State College, PA, USA; Nancy Leidy, PhD, Senior Vice President Scientific Affairs, United BioSource Corp., Bethesda, MD, USA; Charles D Petrie, PhD, Senior Director/Group Leader, Neurosciences, Pfizer, Global Outcomes Research, Groton, CT, USA; Margaret Rothman, PhD, Senior Director, WW Patient Reported Outcomes Center of Excellence, Johnson & Johnson Pharmaceutical Services, LLP, Washington, GA, USA
    * Discussion Leaders represent the ISPOR PRO Existing Instruments & their Modification Task Force.  Members:  Laurie B Burke RPh, MPH; Pennifer Erickson PhD; Nancy Kline Leidy PhD; Donald Patrick PhD, MSPH; Charles Petrie PhD; Margaret Rothman PhD (Chair)
     
    May 7- Workshops-Session IV
     
    Capturing the Impact of Heterogeneity in Pharmacoeconomic Evaluation
    Discussion Leaders: Denis Getsios BA, Research Scientist, Kristen Migliaccio-Walle BS, Research Scientist, Duygu Bozkaya MSc, MBA, Researcher; United BioSource Corp., Concord, MA, USA
     
    Real-Life Patient Reported Outcomes: A Novel Use of the FDA Adverse Event Reporting System (Aers) Safety Database
    Discussion Leaders: Matthew W Reynolds, PhD, Director, United BioSource Corp., Medford, MA, USA.; Donald Stull, PhD, United BioSource Corp., Bethesda, MD, USA; Bob Nordyke, Director Global Health Economics, Amgen, Thousand Oaks, CA, USA
     
    Training Considerations for Patient-Reported Outcomes
    Discussion Leaders: Adam John Butler, Sr., Assistant Vice-President, Training and Education,
    United BioSource Corp., Wayne, PA, USA; Anne M Rentz, MSPH, Research Scientist, United
    BioSource Corp., The Center for Health Outcomes Research, Bethesda, DC, USA
     
    Poster Presentations
     
    Session I: May 5, 2008
     
    A Novel Approach to Adjust for the Impact on Survival Resulting from Patient Cross-Over from Control to Experimental Treatment in Clinical Trials
    Ishak JK, Deniz B, Drayson M, Morgan G, Augustson B, Child T, Begum G, Dunn JA, Shearer A, Caro JJ
     
    A Systematic Review of Low Back Pain Cost of Illness Studies in the United States
    Dagenais S, Caro JJ, Haldeman S
     
    Budget Impact of Adding Doripenem to a Hospital Formulary
    Kongnakorn T, Merchant S, Akhras K, Ingham M, Mody S, Mwamburi M, Caro JJ
     
    Cost-Effectiveness of Quetiapine in Combination with Lithium or Divalproex: In the Maintenance Treatment of Bipolar I Disorder
    Woodward TC, Lazarus A, Quon P, Tafesse E, Fleurence RL
     
    Discovering the Structure of the Power of Food Scale (PFS) in Obese Patients
    Cappelleri JC, Bushmakin AG, Gerber RA, Leidy NK, Sexton C, Karlsson J, Lowe MR
     
    Economic Evaluation of Lenolidomide Use for Multiple Myeloma in Scotland in Patients Who Have Received One Prior Therapy
     
    Evaluation of Interviewer Training for an Interviewer-Administered Patient-Reported Outcome in a Global Clinical Trial

    Major Depressive Disorder: A Comprehensive Literature Review of the Burden of Illness in North America
    Van Hanswijck de Jonge P, Stafford M, Hearn S, Tschaut N, Svedsater H, Locklear JC, Revicki D, Brown R, Trivedi M
     
    Generalized Anxiety Disorder: A Comprehensive Literature Review of the Burden of Illness in North America
    Wyrwich K, Stoeckl Mattera M, Svedsäter H, Locklear JC, Revicki D, Sheehan DV
     
    Medical Costs Associated with Treatment Change in Multiple Sclerosis
    Nordstrom BL, Seaman C, Reynolds MW, Rajagopalan K
     
    Patient-Reported Measures as Quality Assurance Tools in CNS Clinical Trials
    Daniel DG, Friedmann B, Butler A
     
    Psychometric Analysis of the Three-Factor Eating Questionnaire: Results from a Large Diverse Sample of Obese and Non-Obese Subjects
    Cappelleri JC, Bushmakin AG, Gerber RA, Leidy NK, Sexton C, Lowe MR, Karlsson J
     
    Validation of a Nocturnal Gastroesophageal Reflux Disease (GERD) Symptom Severity and Impact Instrument
    Harding G, Roberts L, Spiegel BM, Mody RR, Revicki D, Kahrilas PJ, Camilleri ML, Walter K
     
    Session I: May 6, 2008
     
    Assessing Patient Descriptions of Lower Urinary Tract Symptoms (LUTS) and Perspectives on Treatment Outcomes for the Development of a New LUTS Patient Reported Outcome Tool
    Coyne KS, Sexton C, Kopp Z, Symonds T, Aiyer L, Kaplan S, Chapple C, Wein AJ
     
    Blood Pressure Success Zone Longitudinal Study Success (BPSZ-BLISS). An Observational Multi-Center Study of the Impact of the BPSZ Educational Program on Blood Pressure Control, Persistence, Compliance, and Treatment Satisfaction. Enrollment Metrics and Baseline Cohort Characteristics
    Payne K, Ishak, KJ, Caro JJ, Khan ZM, Stark K,Flack JM, Velázquez EJ, Nesbit SD, Califf R for the BPSZ-BLISS Study Steering Committee
     
    Ceiling Effects and Discrimination of Treatment Benefit for Patients with Lower Symptom Severity: Measurement of Health Utilities in Allergic Rhinitis
    Stull D, O'Quinn S, Vestenbaek U, Navaratnam P
     
    Does the Funding Source Influence the Results in Economic Evaluations? A Case Study in Biophosphonates for the Treatment of Osteoporosis
    Fleurence RL, Spackman E, Hollenbeak C
     
    Health Economics of Asthma: Assessing the Value of Asthma Interventions
    Spackman DE, Campbell JD, Sullivan SD
     
    Informing Decision Makers in Germany: The IQWiG Approach
    Caro JJ, Kolominsky-Rabas P, McGregor M, Henry D
     
    Interpreting Clinical Trials Results for the Onset of Effect Questionnaire: Methods and Results of Delphi Panel
    Harding G, Leidy NK, Kleinman L, Meddis D, Wagner S

    Navigating the Turbulent Evidence Waters: A Suggested Game Plan for Manufacturers

    The Burden of Nasal Congestion in the United States
    Stull DE, Ivanova JI, Long G, Birnbaum H, Crespi S, Sandor DW
     
    Validation of an Abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) Among Patients on Antihypertensive Medications
    Bharmal M, Payne K, Atkinson M, Gemmen EK

  • Drug Development for Neurodegenerative Conditions, Center for Business Intelligence

    Apr 30 - May 1 2008
    Washington, DC
    www.cbinet.com/neuro

    Presentation
    Ensuring Ratings Quality for CNS Clinical Trials
    Butler A

  • Second Annual Pharmaceutical Pricing and Market Access Summit Post-Meeting Workshop: Evidence Based Health Care

    Apr 25 - Apr 25 2008
    London, UK
    www.healthnetworkcommunications.com/events/pharmaceutical_pricing_summit.html#workshop
    Presentations
    Design and Evaluation of Risk Minimization Action Programs (RiskMAPs)
     
    Acquiring the Data for EBHA – Meta Analysis Beast or Saviour?
    Interrelationship of Patient-Reported Outcomes and EBHC
     
    Health Economic Tools – Applying Evidence to HTAs
    The Ethics of HTAs
    What Does This Mean to Pharma and Biotech Companies?

  • 43rd Annual Meeting of the European Association for the Study of Liver (EASL 2008)

    Apr 23 - Apr 27 2008
    Milan, Italy
    www.easl.ch/liver-meeting/index.asp
    Poster Presentations
    Cost-Effectiveness Simulation Analysis of Tenofovir Disoproxil Fumarate (Tenofovir), Lamivudine, Adefovir Dipivoxil (Adefovir) and Entecavir of HBeAg Negative (-) Patients with Chronic Hepatitis-B (CHB) in Spain
    Deniz B, Buti M, Brosa M, Casado MA, Rueda M, Everhard F, Esteban R

    Cost-Effectiveness Simulation Analysis of Tenofovir Disoproxil Fumarate (Tenofovir) in HBeAg Negative (-) Patients with Chronic Hepatitis-B (CHB) in Italy and France
    Deniz B, Everhard F

  • Evidence Synthesis for Decision Modelling Workshop: 5 Day Course

    Apr 14 - Apr 18 2008
    Boston, MA, USA
    www.le.ac.uk/hs/kra1/Boston2008.pdf
    UBC is organizing the Evidence Synthesis for Decision Modelling workshop in collaboration with faculty from the Universities of Leicester and Bristol (UK). This is the first time the course will be conducted in the United States.

    This course is intended for:
    (a) Anyone undertaking health technology assessments, including cost-effectiveness analyses,
    (b) Statisticians, with or without experience in meta-analysis, who wish to learn about Bayesian methods for evidence synthesis particularly in the context of cost-effectiveness analysis.

    The methods taught on the course are designed to be compatible with the recent guidance issued by the National Institute for Clinical Excellence, requiring probabilistic methods in cost-effectiveness models. The course focuses particularly on Bayesian methods for evidence synthesis that can be integrated within a probabilistic modelling framework, and can be used to statistically combine evidence from a range of structures. The course is built around a series of examples using the WinBUGS statistical software.

  • British Society for Haematology (BSH) 48th Annual Scientific Meeting incorporating the 6th Bi-Annual I-FBM Leukaemia Symposium

    Apr 7 - Apr 9 2008
    Scottish Exhibition and Conference Centre (SECC), Glasgow, Scotland, United Kingdom
    www.b-s-h.org.uk/
    Poster Presentations
    Economic Evaluation of Lenalidomide for the Treatment of Multiple Myeloma in Scotland in Patients Who Have Received One Prior Therapy
     
    Modeling Overall Survival in the Event of Patient Cross-Over from Dexamethasone to Lenalidomide in Phase III Multiple Myeloma Trials
    Ishak JK, Deniz B, Drayson M, Morgan G, Augustson B, Child T, Begum G, Dunn JA, Shearer A, Caro JJ

  • 23rd Annual European Association of Urology Congress

    Mar 26 - Mar 29 2008
    Milan, Italy
    www.eaumilan2008.org/
    Poster Presentation
    The Prevalence, Bother, and Overlap of LUTS in the US, UK, and Sweden: EpiLUTS
    Coyne K, Sexton C, Kopp Z, Irwin DE, Milsom I, Aiyer L, Tubaro A, Chapple C, Wein A, on behalf of the EpiLUTS Team

  • 2008 American Association for Geriatric Psychiatry Annual Meeting (AAGP)

    Mar 14 - Mar 17 2008
    Orlando, FL, USA
    www.aagpmeeting.org/

    Presented as part of the symposium: "Dementia Screening in Clinical and Community Settings"
    What to Know When Implementing a Screening Program
    Steffens D, Borson S, Ashford W, Frank L

  • 2008 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI)

    Mar 14 - Mar 18 2008
    Philadelphia, PA, USA
    www.annualmeeting.aaaai.org/
    Oral Presentation
    Use of Fluticasone Propionate/Salmeterol Fixed Combination as Initial Asthma Controller Therapy in Children in a Commercially Insured Population
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G
     
    Poster Presentation
    Comparison of the Congestion Quantifier 5- & 7-item Scales to Monitor Nasal Congestion
    Stull DE, Vernon MK, Meltzer EO, Canonica GW, Sandor DW, Crespi S

  • Society of Urologic Nurses and Associates Annual Symposium (SUNA)

    Feb 28 - Mar 2 2008
    Tampa, FL, USA
    www.suna.org/

    Podium Presentation
    Factors that Contribute to Treatment Satisfaction in Overactive Bladder Patients
    Wyman JF, Harding G, Klutke C, Burgio K, Berriman S, Vasudha V, Bavendam T, Coyne KS

  • International Society for the Study of Women's Sexual Health (ISSWSH) 2008 Annual Meeting

    Feb 21 - Feb 24 2008
    San Diego, CA, USA
    www.isswsh.org/
    Presentations
    The Impact of Lower Urinary Tract Symptoms on Women’s Sexual Health: Results From the EpiLUTS Study
    Coyne K, Sexton C, Kopp Z, Thompson C, Irwin D, Milsom I, Chapple C, Tubaro A, Wein A, and the EpiLUTS Working Group
     
    The Prevalence of Sexual Activity and Sexual Desire in Women:  Results from EpiLUTS
    Coyne K, Sexton C, Kopp Z, Thompson C, Irwin D, Milsom I, Chapple C, Tubaro A, Wein A, and the EpiLUTS Working Group

  • International Stroke Conference 2008 (ISC)

    Feb 20 - Feb 22 2008
    New Orleans, LA, USA
    www.americanheart.org/
    Poster Presentation
    Atorvastatin for Secondary Stroke Prevention: an Economic Evaluation of the SPARCL Trial Using Discrete Event Simulation
    Kongnakorn T, Ward A, Roberts CS, O'Brien JA, Proskorovsky I, Caro JJ

  • 14th Biennial Winter Workshop on Schizophrenia & Bipolar Disorders

    Feb 3 - Feb 7 2008
    Montreux, Switzerland
    www.winterworkshop.org
    Poster Presentation
    Clinical and Economic Outcomes of Atypical Antipsychotics in Schizophrenia
    Sorensen S, Nasrallah H, Cragin LS, BakerTM, Harnett J, Sanders KN, Kremer C

  • The 7th International Conference on Health Policy Statistics 2008

    Jan 17 - Jan 18 2008
    Philadelphia, PA, USA
    www.amstat.org/meetings/ichps/2008/
    Oral Presentation
    Value of Information (VOI): Is It Ready for Prime Time?
    Presented by Jaime J. Caro, MD, Senior Vice President of Health Economics, Senior Research Scientist, United BioSource Corporation

  • 7th Annual DIA Conference for Contemporary Pharmacovigilance and Risk Management Strategies

    Jan 13 - Jan 17 2008
    Washington, DC, USA
    www.diahome.org
    Oral Presentation
    Epidemiology During Drug Development: Applying Natural History of Disease to Understanding Safety
    Matthew W. Reynolds, PhD, Senior Director, Epidemiology and Risk Management, United BioSource Corporation